Sanofi offers to buy U.S. biotech, mRNA partner Translate Bio -sources
Tuesday, 3 August 2021, 00:27:08
PARIS Sanofi has offered to buy U.S. biotech company Translate Bio, two sources familiar with the situation said on Monday, as the French drugmaker bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race. Shares in the New York-listed biotech company soared more than 70% to above $50 in extended trading, building []
— Financial Post
Sanofi preps a multibillion-dollar buyout of an mRNA pioneer after falling behind in the race for a Covid-19 jab report
Tuesday, 3 August 2021, 00:08:25
It looks like Sanofi CEO Paul Hudson is dead serious about his intention to vault directly into contention for the future of mRNA vaccines. A year after paying Translate Bio a whopping $425 million in an upfront and equity payment to help guide the pharma giant to the promised land
— Endpoints News
Translate Bio surges in after hours on report of Sanofi bid
Monday, 2 August 2021, 23:49:41
No summary available.
— Seeking Alpha
Global Hydroxychloroquine Market Is Growing Rapidly as Sanofi and Teva Pharmaceutical announces to donate millions of doses of Hydroxychloroquine for the treatment of COVID-19
Monday, 2 August 2021, 15:30:31
Hydroxychloroquine (Plaquenil and Hydrochloroquin) are commonly used in the treatment of osteoarthritis. Hydroxychloroquine and Hydroxyquinone (Dilantin) are considered “anti-inflammatory” medicines. They inhibit the action of prostaglandins and leukotrienes on the skin, joints, and tendons. It can reduce swelling and pain
— OpenPR
Hydroxychloroquine Market 2021-2027 | To Reach USD 2,339.1 Million by 2027, Exhibit a CAGR of 5.5%
Monday, 2 August 2021, 14:20:00
Key Prominent Players Covered in the Hydroxychloroquine Market Research Report Are Sanofi , Zydus Cadia , Ipca Laboratories Ltd , Sandoz International GmbH (part of Novartis AG) , Mylan N.V. , Teva Pharmaceutical Industries Ltd , Bayer AG Key Prominent Players Covered in the Hydroxychloroquine Market Research Report Are Sanofi , Zydus Cadia , Ipca Laboratories Ltd , Sandoz International GmbH (part of Novartis AG) , Mylan N.V. , Teva Pharmaceutical Industries Ltd , Bayer AG
— Intrado Digital Media
We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.
